These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6153843)

  • 1. Two cases of scleromyxedema.
    Jepsen LV
    Acta Derm Venereol; 1980; 60(1):77-79. PubMed ID: 6153843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleromyxedema.
    Wright RC; Franco RS; Denton D; Blaney DJ
    Arch Dermatol; 1976 Jan; 112(1):63-6. PubMed ID: 813582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleromyxedema.
    Chanda JJ
    Cutis; 1979 Nov; 24(5):549-52. PubMed ID: 520033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of scleromyxedema with melphalan.
    Harris RB; Perry HO; Kyle RA; Winkelmann RK
    Arch Dermatol; 1979 Mar; 115(3):295-9. PubMed ID: 434843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scleromyxedema: An experience using treatment with systemic corticosteroid and review of the published work.
    Lin YC; Wang HC; Shen JL
    J Dermatol; 2006 Mar; 33(3):207-10. PubMed ID: 16620228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scleromyxedema. A dramatic response to melphalan.
    Feldman P; Shapiro L; Pick AI; Slatkin MH
    Arch Dermatol; 1969 Jan; 99(1):51-6. PubMed ID: 4178219
    [No Abstract]   [Full Text] [Related]  

  • 7. [Initial scleromyxedema. Successful treatment with melphalan].
    Schubert K; Stein A; Meurer M
    Hautarzt; 2002 Jul; 53(7):478-82. PubMed ID: 12219271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation.
    Lacy MQ; Hogan WJ; Gertz MA; Dispenzieri A; Rajkumar SV; Hayman S; Kumar S; Litzow MR; Schroeter AL
    Arch Dermatol; 2005 Oct; 141(10):1277-82. PubMed ID: 16230566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis.
    Jablonska S; Blaszczyk M
    Eur J Dermatol; 1999; 9(7):551-4. PubMed ID: 10523735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arndt-Gottron scleromyxedema and associated phenomena].
    Lang E; Zabel M; Schmidt H
    Dermatologica; 1984; 169(1):29-35. PubMed ID: 6432594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of scleromyxedema associated with isotretinoin therapy.
    Hisler BM; Savoy LB; Hashimoto K
    J Am Acad Dermatol; 1991 May; 24(5 Pt 2):854-7. PubMed ID: 2050852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermabrasion for lichen amyloidosus. Report of a long-term study.
    Wong CK; Li WM
    Arch Dermatol; 1982 May; 118(5):302-4. PubMed ID: 7082019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleromyxedema: systemic manifestations and cosmetic improvement from dermabrasion.
    Kaufman D; Truhan AP; Roenigk HH
    Cutis; 1987 Apr; 39(4):321-4. PubMed ID: 3581903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins.
    Wojas-Pelc A; Błaszczyk M; Glińska M; Jabłońska S
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):462-5. PubMed ID: 15987294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of intractable scleromyxedema with cyclosporin A.
    Saigoh S; Tashiro A; Fujita S; Matsui M; Shibata S; Takeshita H; Duan H; Moroi Y; Urabe K; Koga T; Furue M
    Dermatology; 2003; 207(4):410-1. PubMed ID: 14657639
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis, and pretibial myxedema.
    Jolles S; Hughes J
    Int Immunopharmacol; 2006 Apr; 6(4):579-91. PubMed ID: 16504920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleromyxedema: successful treatment of cutaneous and neurologic symptoms.
    Nieves DS; Bondi EE; Wallmark J; Raps EC; Seykora JT
    Cutis; 2000 Feb; 65(2):89-92. PubMed ID: 10696560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scleromyxedema: case for therapeutic suggestion.
    Vossaert K; Naeyaert JM; Mestdagh M
    Dermatologica; 1990; 180(3):189-90. PubMed ID: 2340934
    [No Abstract]   [Full Text] [Related]  

  • 19. The acquired cutaneous mucinoses.
    Matsuoka LY; Wortsman J; Carlisle KS; Kupchella CK; Dietrich JG
    Arch Intern Med; 1984 Oct; 144(10):1974-80. PubMed ID: 6486981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arndt-Gottron scleromyxedema; treatment with melphalan].
    Hadida E; Sayag J
    Arch Belg Dermatol Syphiligr; 1969; 25(3):299-304. PubMed ID: 4100854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.